Revive Therapeutics Ltd. (RVV)

Revive Therapeutics Logo White

Revive Therapeutics

CSE: RVV | OTC: RVVTF 

Revive Therapeutics is focused on the R&D and sale of cannabinoid-based products, recently expanding into the psychedelics industry more broadly.

Revive Therapeutics
$0.4100
-1.20%
$0.0000

Latest News

Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19

June 30, 2020

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

June 12, 2020

Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting

June 9, 2020

Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19

June 3, 2020

Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives

May 13, 2020

Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

April 29, 2020

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.